Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
Esophageal Cancer
Interventions
PROCEDURE

Blood sampling

Before any study treatment, 14 days after radiotherapy, 15 weeks after radiotherapy

RADIATION

Radiation

Week 1 to week 5-6 1.8-2 Gys/fraction, 5 days a week for a total of 5 to 6 weeks

DRUG

Chemotherapy (Fluorouracil and Cisplatin)

"At weeks 1, 5, 8 and 11~* Day 1 to day 4: Fluorouracil 1 gr/m²/day~* Day 1 or 2: Cisplatin 75 mg/m²"

Trial Locations (6)

14046

Centre François BACLESSE, Caen

29200

Centre Hospitalier Universitaire, Brest

35042

Centre Eugène Marquis, Rennes

49933

Centre Paul Papin, Angers

59020

Centre Oscar Lambret, Lille

76031

CHU - Hopital Charles Nicolle, Rouen

All Listed Sponsors
lead

Centre Oscar Lambret

OTHER

NCT00911092 - Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer | Biotech Hunter | Biotech Hunter